Assessment of liver stiffness in patients after living donor liver transplantation by transient elastography

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 9, 2009, Pages 1115-1120

  Masuzaki, Ryota ^a   Yamashiki, Noriyo ^a   Sugawara, Yasuhiko ^a   Yoshida, Haruhiko ^a   Tateishi, Ryosuke ^a   Tamura, Sumihito ^a   Kaneko, Junichi ^a   Hasegawa, Kiyoshi ^a   Kokudo, Norihiro ^a   Makuuchi, Masatoshi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Liver fibrosis; Living donor liver transplantation; Transient elastography

Indexed keywords

ALPHA2B INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2B; PREDNISOLONE; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; ELASTOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; BIOPSY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 70350666808     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520903078810     Document Type: Article

References (44)

1. European Liver Transplantation Registry. Available at: http// www.eltr.org (accessed May 2009).
2. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007;/25:/310-2.
3. Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002;/35:/ 680-7.
4. Gane EJ, Portmann BC, Naoumov NV, Smith HM, UnDerhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;/ 334:/815-20.
5. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High inciDence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episoDes. Hepatology 1999;/29:/250-6.
6. Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004;/40:/699-707.
7. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000;/32:/ 673-84.
8. Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996;/61:/701-5.
9. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;/122:/889-96.
10. Troppmann C, Rossaro L, Perez RV, McVicar JP. Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation. Am J Transplant 2003;/3:/239-40.
11. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005;242:314-23, discussion 323-5.
12. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004;/10:/340-6.
13. Van Vlierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, De Hemptinne B. Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 2004;/77:/210-4.
14. Sugawara Y, Makuuchi M, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, et al. Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation 2004;/78:/ 1308-11. (Pubitemid 39507969)
15. Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004;/ 41:/830-6.
16. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;/38:/ 1449-57. (Pubitemid 37466971)
17. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;/41:/ 257-64.
18. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;/128:/343-50.
19. De Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Def Synd 2006;/41:/175-9.
20. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;/ 55:/403-8.
21. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne- Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;/45:/230-5.
22. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;/29:/1705-13.
23. Ganne-Carrie N, Ziol M, De Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;/44:/1511-7.
24. Masuzaki R, Tateishi R, Yoshida H, Sato T, Ohki T, Goto T, et al. Assessing liver tumor stiffness by transient elastography. Hepatol Int 2007;/1:/394-7.
25. Sugawara Y, Makuuchi M. AdVances in adult living donor liver transplantation: a review based on reports from the 10th anniversary of the adult-to-adult living donor liver transplantation meeting in Tokyo. Liver Transpl 2004;/10:/715-20.
26. Mladinich CR, Ackerman N, Berry CR, Buergelt CD, Longmate J. Evaluation and comparison of automated biopsy Devices. Work in progress. Radiology 1992;/184:/ 845-7.
27. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;/19:/1513-20.
28. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 1998;/25:/1032-7.
29. Tukey JW. Some selected quick and easy methods of statistical analysis. Trans NY Acad Sci 1953;/16:/88-97.
30. YouDen WJ. InDex for rating diagnostic tests. Cancer 1950;/3:/ 32-5.
31. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;/50:/ 1344-55.
32. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive inDex can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;/38:/518-26.
33. McHutchison JG, Blatt LM, De Medina M, Craig JR, Conrad A, Schiff ER, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000;/15:/945-51.
34. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;/42:/282-92.
35. Benlloch S, Berenguer M, Prieto M, Rayon JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive inDex. Liver Transpl 2005;/11:/456-62.
36. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of adVanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;/12:/ 1791-8.
37. Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita Y, et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008;/85:/ 69-74.
38. Bahra M, Neumann UP, Jacob D, Langrehr JM, Berg T, Neuhaus R, et al. Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy). Transplantation 2007;/83:/351-3.
39. Berenguer M, Prieto M, Rayon JM, Mora J, Pastor M, Ortiz V, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000;/32:/852-8.
40. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003;/38:/ 1282-8.
41. Castells L, Vargas V, AllenDe H, Bilbao I, Luis Lazaro J, Margarit C, et al. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol 2005;/43:/53-9.
42. Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M, et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology 2005;/41:/289-98. (Pubitemid 40165372)
43. Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006;/18:/411-2.
44. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepatol 2009;/16:/300-14.